Hutchison China MediTech Limited Sponsored ADR Forecast, price target & analysts
Hutchison China MediTech Limited Sponsored ADR Target price 2026 - Analyst rating & recommendation
Hutchison China MediTech Limited Sponsored ADR Classifications & Recommendation
Hutchison China MediTech Limited Sponsored ADR Price Target
| Target Price | $3.89 |
| Price | $13.67 |
| Deviation |
71.51%
register free of charge
|
| Number of Estimates | 17 |
|
17 Analysts have issued a price target Hutchison China MediTech Limited Sponsored ADR 2027 .
The average Hutchison China MediTech Limited Sponsored ADR target price is $3.89.
This is
71.51%
register free of charge
$5.63
58.78%
register free of charge
$2.45
82.11%
register free of charge
|
|
| A rating was issued by 28 analysts: 23 Analysts recommend Hutchison China MediTech Limited Sponsored ADR to buy, 5 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Hutchison China MediTech Limited Sponsored ADR stock has an average upside potential 2027 of
71.51%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2030
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 548.51 | 642.36 |
| 12.96% | 17.11% | |
| EBITDA Margin | -4.71% | 3.00% |
| 5.29% | 163.66% | |
| Net Margin | 83.30% | 9.28% |
| 1,291.35% | 88.86% |
21 Analysts have issued a sales forecast Hutchison China MediTech Limited Sponsored ADR 2026 . The average Hutchison China MediTech Limited Sponsored ADR sales estimate is
This results in the following potential growth metrics:
15 Analysts have issued an Hutchison China MediTech Limited Sponsored ADR EBITDA forecast 2026. The average Hutchison China MediTech Limited Sponsored ADR EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
22 Hutchison China MediTech Limited Sponsored ADR Analysts have issued a net profit forecast 2026. The average Hutchison China MediTech Limited Sponsored ADR net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 0.52 | 0.07 |
| 1,200.00% | 86.54% | |
| P/E | 200.09 | |
| EV/Sales | 1.78 |
22 Analysts have issued a Hutchison China MediTech Limited Sponsored ADR forecast for earnings per share. The average Hutchison China MediTech Limited Sponsored ADR EPS is
This results in the following potential growth metrics and future valuations:
Hutchison China MediTech Limited Sponsored ADR...
Current Hutchison China MediTech Limited Sponsored ADR Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Sep 22 2025 |
| B of A Securities |
Locked
➜
Locked
|
Locked | Jul 22 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Sep 22 2025 |
|
Locked
B of A Securities:
Locked
➜
Locked
|
Jul 22 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
